Veradigm Appoints Don Trigg as Chief Executive Officer
Former apree health CEO, Cerner President will Lead Next Phase of Company Growth Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced...
Category : HealthTech
Blueberry Pediatrics Announces New AI Health Leadership Team
With top talent from MDLive and Teladoc, Blueberry is poised to transform pediatric healthcare with AI-powered telehealth. Blueberry Pediatrics, the 24/7 AI-enabled pediatric care company...
Atropos, Novartis Use AI to Speed Up Rare Disease Diagnosis
Real-World Evidence and Longitudinal Patient Records-Driven Algorithm Delivers Actionable, AI-Powered Insights at the Point of Care Atropos Health, a leader in translating real-world clinical data...
Ant Group Launches AI-Driven Campaign to Combat Health Misinformation
Ant Group has rolled out a major initiative through its AI healthcare app AQ to combat health misinformation in China, with a special focus on protecting seniors....
Sectra Eases Cloud Adoption for German Healthcare with New Attestation
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received the security attestation Cloud Computing Compliance Criteria Catalogue (C5) for its Software-as-a-Service (SaaS) for enterprise...
Oracle Ushers in New Era of AI-Driven Electronic Health Records
Built from the ground up with the latest AI technology, Oracle’s next-generation EHR delivers intelligence that helps clinicians focus time on patients, provide more informed...
Rhapsody Introduces Image Director
New DICOM routing and imaging integration solution saves radiologist time, reduces vendor sprawl, powers multi-modal exchange, and accelerates AI ROI for imaging networks, IDNs and...
HopeAI Unveils AI Synthetic Data to Accelerate Cancer Trials
HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and executed. At the 2025 American Society of Clinical...
Tevogen.AI, Microsoft & Databricks Build Beta PredicTcell Model
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its artificial intelligence initiative, Tevogen.AI, is expanding its collaboration with Microsoft (Nasdaq: MSFT) and Databricks, to...
Artera Gets FDA Nod for AI Pathology Tool in Prostate Cancer
Novel risk stratification tool advances the frontier of precision oncology by providing access to insights informing critical on-the-ground treatment decisions Artera, the developer of multimodal...